Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | USP2 | O75604 | 2/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | GPBAR1 | Q8TDU6 | 9/20 | 0.75 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.75 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.75 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.75 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | CA2 | P00918 | 4/20 | 0.70 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | VDR | P11473 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.60 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5436906 | 0.93 | MAPT (0.80) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL5437748 | 0.91 | MAPT (0.77) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL26424135 | 0.91 | MAPT (0.77) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL31452985 | 0.91 | MAPT (0.77) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL22699678 | 0.91 | MAPT (0.83) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL4971166 | 0.91 | MAPT (0.83) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL137537 | 0.91 | MAPT (0.76) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL23710355 | 0.90 | MAPT (0.81) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL5431048 | 0.90 | MAPT (0.81) | MAPTMEN1KMT2AUSP2MAPK1 | |
| SCHEMBL18216458 | 0.90 | MAPT (0.81) | MAPTMEN1KMT2AUSP2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | claimed |
| US-20260062565-A1 | SELF-DISINFECTING AND PATHOGEN ERADICATING COATING WITH SPORE GERMINATION AGENT, ARTICLE COMPRISING THE COATING AND METHOD OF APPLICATION | KISMET TECH INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250367242-A1 | DESIGNED BACTERIAL COMPOSITIONS AND USES THEREOF | SERES THERAPEUTICS, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250345398-A1 | AGENTS AND METHODS FOR TREATING DISEASE | BIOXEL, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4642923-A1 | DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE | IDEXX Laboratories, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4620486-A1 | CONJUGATES OF G-PROTEIN COUPLED RECEPTOR AGONISTS AND ANTAGONISTS | Bioxel, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-12403100-B2 | Natural combination products and methods for regulation of total blood cholesterol | PURE CARE PRO LLC (US) | 2025-09-02 | — | — | US | disclosed |
| US-12173363-B2 | Absolute quantification of nucleic acids and related methods and systems | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-12-24 | — | — | US | disclosed |
| US-12173361-B2 | Rodent model and related device, compositions, methods and systems | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2024-12-24 | — | — | US | disclosed |
| US-20240218421-A1 | DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE | IDEXX LABORATORIES, INC. | 2024-07-04 | — | — | US | disclosed |
| WO-2017223409-A1 | DIAGNOSTIC AND THERAPEUTIC METHODS RELATED TO INFLAMMATORY BOWEL DISEASES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-12-28 | — | — | WO | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| EP-1408982-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DIGESTIVE DISORDERS AND ASSOCIATED DISEASES | Feher, Janos (HU) | 2004-04-21 | — | — | EP | disclosed |
| US-20040038952-A1 | Pharmaceutical compositions for treatment of digestive disorders and associated diseases | FEHER JANOS (HU) | 2004-02-26 | — | — | US | disclosed |
| WO-2002047694-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DIGESTIVE DISORDERS AND ASSOCIATED DISEASES | FEHER JANOS (HU) | 2002-06-20 | — | — | WO | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062565-A1 | SELF-DISINFECTING AND PATHOGEN ERADICATING COATING WITH SPORE GERMINATION AGENT, ARTICLE COMPRISING THE COATING AND METHOD OF APPLICATION | POLR1C, CD63, CD4 | MAPT 568/4885MEN1 1680/4885KMT2A 4316/4885 |
| US-20250345398-A1 | AGENTS AND METHODS FOR TREATING DISEASE | ARRB1, GPR68, GPBAR1 | MAPT 1915/4885MEN1 4078/4885KMT2A 3745/4885 |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | MAPT 3617/4885MEN1 1210/4885KMT2A 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.